Literature DB >> 19275580

HIV-1 Vpr: a closer look at the multifunctional protein from the structural perspective.

Ramesh C Pandey1, Debduti Datta, Ruma Mukerjee, Alagarsamy Srinivasan, Sundarasamy Mahalingam, Bassel E Sawaya.   

Abstract

The human immunodeficiency virus-1 (HIV-1) Vpr protein plays multiple roles in HIV-1 replication. In early infection, Vpr provides help in the nuclear localization of pre-integration complex. Subsequently, Vpr induces cell cycle arrest of infected cells at G2/M phase. Cell cycle arrest facilitates higher rate of viral gene transcription. Vpr is also capable of activating transcription of viral and heterologous genes. Vpr induces apoptosis in infected cells leading to loss of immune cells and onset of clinical AIDS. Interestingly, Vpr is also considered as a passenger protein in the virus particles as it is incorporated into the virus particles through interaction with Gag. The structure of full length Vpr has been resolved recently through NMR. In this review, we have analysed the functions of Vpr using the available data from structural perspective. Packing of the three helices of Vpr around a core formed by hydrophobic side chains and integrity of helical domains are critical for Vpr functions. The distinct functions of Vpr have been attributed to structural integrity of different domains. The unique distribution of acidic and basic residues in Vpr is an interesting feature. Two hydrophobic pockets on the structure of Vpr are proposed to be important targets for modulating Vpr functions. The inter-relationship between different functions of Vpr is discussed in the context of structure. Based on bioinformatics analysis, we propose new targets for modulating Vpr functions, which need to be validated experimentally.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19275580     DOI: 10.2174/157016209787581508

Source DB:  PubMed          Journal:  Curr HIV Res        ISSN: 1570-162X            Impact factor:   1.581


  11 in total

1.  Deregulation of microRNAs by HIV-1 Vpr protein leads to the development of neurocognitive disorders.

Authors:  Ruma Mukerjee; J Robert Chang; Luis Del Valle; Asen Bagashev; Monika M Gayed; Randolph B Lyde; Brian J Hawkins; Eugen Brailoiu; Eric Cohen; Chris Power; S Ausim Azizi; Benjamin B Gelman; Bassel E Sawaya
Journal:  J Biol Chem       Date:  2011-08-04       Impact factor: 5.157

2.  Vipirinin, a coumarin-based HIV-1 Vpr inhibitor, interacts with a hydrophobic region of VPR.

Authors:  Eugene Boon Beng Ong; Nobumoto Watanabe; Akiko Saito; Yushi Futamura; Khaled Hussein Abd El Galil; Atsushi Koito; Nazalan Najimudin; Hiroyuki Osada
Journal:  J Biol Chem       Date:  2011-02-28       Impact factor: 5.157

Review 3.  Nanotechnology-based approaches for the development of diagnostics, therapeutics, and vaccines.

Authors:  Alagarsamy Srinivasan; Anshu Rastogi; Velpandi Ayyavoo; Shiv Srivastava
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2014-06

4.  Specific amino acids in HIV-1 Vpr are significantly associated with differences in patient neurocognitive status.

Authors:  Will Dampier; Gregory C Antell; Benjamas Aiamkitsumrit; Michael R Nonnemacher; Jeffrey M Jacobson; Vanessa Pirrone; Wen Zhong; Katherine Kercher; Shendra Passic; Jean W Williams; Tony James; Kathryn N Devlin; Tania Giovannetti; David J Libon; Zsofia Szep; Garth D Ehrlich; Brian Wigdahl; Fred C Krebs
Journal:  J Neurovirol       Date:  2016-07-11       Impact factor: 2.643

Review 5.  Role of p53 in neurodegenerative diseases.

Authors:  J Robert Chang; Mohammad Ghafouri; Ruma Mukerjee; Asen Bagashev; Tinatin Chabrashvili; Bassel E Sawaya
Journal:  Neurodegener Dis       Date:  2011-10-28       Impact factor: 2.977

6.  Exposed hydrophobic residues in human immunodeficiency virus type 1 Vpr helix-1 are important for cell cycle arrest and cell death.

Authors:  R Anthony Barnitz; Benjamin Chaigne-Delalande; Diane L Bolton; Michael J Lenardo
Journal:  PLoS One       Date:  2011-09-16       Impact factor: 3.240

7.  Cellular phenotype impacts human immunodeficiency virus type 1 viral protein R subcellular localization.

Authors:  Adriano Ferrucci; Michael R Nonnemacher; Brian Wigdahl
Journal:  Virol J       Date:  2011-08-10       Impact factor: 4.099

8.  Regulation of the HIV-1 promoter by HIF-1α and Vpr proteins.

Authors:  Satish L Deshmane; Shohreh Amini; Satarupa Sen; Kamel Khalili; Bassel E Sawaya
Journal:  Virol J       Date:  2011-10-24       Impact factor: 4.099

9.  HIV-1 Vpr triggers mitochondrial destruction by impairing Mfn2-mediated ER-mitochondria interaction.

Authors:  Chih-Yang Huang; Shu-Fen Chiang; Tze-Yi Lin; Shiow-Her Chiou; Kuan-Chih Chow
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

10.  Development of a robust cell-based high-throughput screening assay to identify targets of HIV-1 viral protein R dimerization.

Authors:  Courtney Zych; Alexander Domling; Velpandi Ayyavoo
Journal:  Drug Des Devel Ther       Date:  2013-05-24       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.